Protocol Ledger

NCT05029635 · Phase III · COMPLETED

Phase III Study on HMPL-523 for Treatment of ITP

Interventional Phase III clinical trial protocol NCT05029635 sponsored by Hutchmed in Rare Genetic, Women's Health, and Other, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2021-10-27 Enrollment: 272 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT05029635
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)272 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05029635
Protocol FieldVerified Registry Value
NCT IdentifierNCT05029635
Consolidated Lead SponsorHutchmed
Therapeutic Condition CohortRare Genetic, Women's Health, and Other
Clinical Trial PhasePhase III
Overall Recruitment StatusCOMPLETED
Registered Enrollment272 participants (ACTUAL)
Registered Start Date2021-10-27
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI